Mwandishi:
Dkt. Mercy M, CO
Mhariri:
Dkt. Benjamin L, MD
Hydralazine ni moja kati ya dawa inayotumika kushusha shinikizo la juu la damu na kuzuia magonjwa kama kiharusi, magonjwa ya moyo na figo. Inafanya kazi kwa kutanua mishipa ya damu.
Majina mengine ya Hydralazine
Majina mengine ya Hydralazine ni;
Apresoline
Bidil
Hydralazine ipo kundi gani la dawa?
Hydralazine ni dawa iliyo katika kundi la Vasodilators.
Dawa zilizo kundi moja na Hydralazine
Dawa zilizo kundi moja na Hydralazine ni ;
Nitrogycerin
Isosorbide mononitrate
Isosorbide dinitrate
Minoxidil
Fenoldopam
Nitroprusside
Fomu ya dawa ya Hydralazine
Dawa hii ipo katika fomu ya;
Solusheni kwaajiri ya sindano
Kidonge
Uzito wa dawa ya Hydralazine
Hydralazine ina uzito ufuatao;
Solusheni kwaajiri ya sindano
20mg/ml
Vidonge
10mg
25mg
50mg
100mg
Hydralazine hutibu nini?
Hutumika kutibu shinikizo la damu iliyo juu
Hutumika kutibu shinikizo la damu kwa wajawazito (Eclampsia)
Hutumika kutibu congestive heart failure
Namna Hydralazine inavyoweza kufanya kazi
Hydralazine inapoingia kwenye damu hufanya kazi ya kupanua mishipa ya damu moja kwa moja hasa kwenye ateri na veini kidogo hivyo kupunguza shinikizo la damu na kufanya damu izunguke vizuri mwilini.
Ufyozwaji wa dawa
Ufyozwaji wa dawa hii hufanyika vizuri ikitumika na chakula kwani chakula husaidia Kiwango cha dawa kinachoingia kwenye damu baada ya mtu kumeza dawa.
Mwingiliano wa Hydralazine na chakula
Dawa hii ni nzuri kutumika mtu akiwa amepata chakula kwani chakula husaidia katika ufyozwaji wa dawa.
Wagonjwa wasiopaswa kutumia Hydralazine
Wagonjwa wenye mzio wa Hydralazine.
Wagonjwa wenye coronary artery disease.
Wagonjwa wenye mitral valvular rheumatic heart disease.
Utoaji taka wa Hydralazine mwilini
Asilimia kumi na nne (14%) ya dawa ambayo haijabadirishwa hutolewa kwa njia ya mkojo.
Matumizi ya Hydralazine kwa mama mjamzito
Tafiti zinaonesha kuwa tahadhari inatakiwa wakati mama mjamzito anatumia dawa hii inaweza kuleta madhara kwa mtoto aliye tumboni kwa mama.
Matumizi ya Hydralazine mama anayenyonyesha
Tafiti zinaonesha kuwa dawa hii inatolewa njee kupitia maziwa ya mama hivyo tahadhari inatakiwa wakati mama anayeyonyesha anapotumia dawa hii.
Dawa zenye muingiliano na Hydralazine
Dawa zenye mwingiliano mkali na hivyo kutofaa kutumika pamoja na Hydralazine;
Lofexidine
Lonafarnib
Pexidartinib
Pretomanid
Dawa zinazoweza kutumika na Hydralazine chini ya uangalizi;
Acebutolol
Aceclofenac
Acemetacin
Aldesleukin
Amifostine
Aspirin
Aspirin rectal
Aspirin/citric acid/sodium bicarbonate
Atenolol
Avanafil
Axitinib
Benzphetamine
Betaxolol
Bisoprolol
Bretylium
Carbidopa
Carvedilol
Celecoxib
Choline magnesium trisalicylate
Dexfenfluramine
Dexmethylphenidate
Dextroamphetamine
Diclofenac
Diethylpropion
Diflunisal
Dobutamine
Dopamine
Ephedrine
Epinephrine
Epoprostenol
Esmolol
Etodolac
Fenfluramine
Fenoldopam
Fenoprofen
Finerenone
Flibanserin
Flurbiprofen
Ibuprofen
Ibuprofen iv
Iloprost
Indomethacin
Labetalol
Lemborexant
Levodopa
Linezolid
Meclofenamate
Mefenamic acid
Meloxicam
Nabumetone
Phenylephrine
Procarbazine
Propranolol
Sulfasalazine
Tazemetostat
Timolol
Tinidazole
Tolfenamic acid
Dawa zenye mwingiliano mdogo na Hydralazine;
Agrimony
Brimonidine
Celiprolol
Cornsilk
Diazoxide
Forskolin
Maitake
Pyridoxine
Pyridoxine (antidote)
Reishi
Ruxolitinib
Shepherd's purse
Tizanidine
Treprostinil
Maudhi madogo ya Hydralazine
Shinikizo la damu kuwa chini
Kichefuchefu
Maumivu ya kichwa
Palpitation
Macho kutoa uchafu na kuwa mekundu
Kichefuchefu
Mapigo ya moyo kuwa juu
Mwili kuvimba
Vascular collapse
Peripheral neuropathy
Kukosa hamu ya kula
Kuharisha
Kutapika
Kizunguzungu
Maumivu ya kifua
Kushindwa kupumua
Leukopenia
Nasal congestion
Rheumatoid arthritis
Agranulocytosis
Mwili kuchoka
Maumivu wakati wa kukojoa au kushindwa kukojoa
Ufanye nini endapo utasahau kutumia dozi yako?
Kama umesahau kutumia dozi yako tumia mara pale utakapokumbuka, kama muda wa dozi inayofata umekaribia usimeze dozi uliyosahau endelea na dozi inayofuata kwa muda uliopangiwa na daktari. Usimeze dozi mbili kufidia uliyosahau.
13 Juni 2023 19:18:46
Dawa hydralazine
Imeboreshwa,
29 Oktoba 2021 15:36:29
Dawa yoyote ni sumu, usitumie dawa pasipo ushauri wa daktari kuepuka madhara kwenye ogani mbalimbali kama figo na ini. Matumizi ya dawa pasipo ushauri wa daktari unaweza kusababisha madhara na usugu wa vimelea vya maradhi kwenye dawa.
​
ULY CLINIC inakushauri siku zote uwasiliane na daktari wako kwa ushauri na tiba kabla ya kuchukua hatua yoyote ile baad aya kusoma makala hii.
Kupata ushauri zaidi na tiba kutoka kwa daktari wa ULY CLINIC bofya Mawasiliano yetu au Pata tiba.
Rejea za mada hii:
Bäck SE, et al. Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males. Scand J Clin Lab Invest. 1989 Nov;49(7):641–646.
Bax RP, et al. The pharmacokinetics of meropenem in volunteers. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):311–320.
Burman LA, et al. Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem. J Antimicrob Chemother. 1991 Feb;27(2):219–224.
Christensson BA, et al. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment. Antimicrob Agents Chemother. 1992 Jul;36(7):1532–1537.
DAVIES DF, SHOCK NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950 May;29(5):496–507.
Douglas JG, et al. The pharmacokinetics of cefuroxime in the elderly. J Antimicrob Chemother. 1980 Jul;6(4):543–549.
Granerus G, et al. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest. 1981 Oct;41(6):611–616.
Harrison MP, et al. The disposition and metabolism of meropenem in laboratory animals and man. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):265–277.
Jones RN, et al. In-vitro studies of meropenem. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):9–29.
Krutzén E, et al. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med. 1984 Dec;104(6):955–961.
Ljungberg B, et al. Pharmacokinetics of antimicrobial agents in the elderly. Rev Infect Dis. 1987 Mar-Apr;9(2):250–264.